BRIEF-Quest Diagnostics Q3 Adjusted EPS USD 3 Vs. IBES Estimate USD 2.86
Reuters2026/10/22 10:47Oct 22 (Reuters) - Quest Diagnostics Q3 net income USD 312 million.
- Q3 revenue USD 3,097 million vs. IBES estimate USD 3,046 million
- Q3 EPS USD 2.78
- outlook FY EPS USD 10.21-10.31
- outlook FY adjusted EPS USD 11.25-11.35 vs. IBES estimate USD 11.2
- outlook FY revenue USD 12,065-12,105 million vs. IBES estimate USD 12,001 million
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bonds Could Become the Hedge Against AI Selloff as Correlation Turns Negative
JPMorgan lowered Boeing's target price to $240.
"For the first time in history" Annual Guidance Released in Advance! JPMorgan Maintains 'Overweight' Rating for ASM International (ASMIY.US), Earnings Outlook May Continue to Improve
JPMorgan maintains an Overweight rating on ASMI with a target price of 1,174 euros, stating that this is the first time the company has provided guidance for 2027. The outlook is highly visible, and profit expectations may be revised up by a low double-digit percentage.
Crypto prices
More
